Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Blood Pressure Management Goals and Targets

Primary Treatment Targets by Patient Category

  • The American College of Cardiology (ACC) and American Heart Association (AHA) recommend a target blood pressure of <130/80 mmHg for most adults under 65 years 5, 6
  • For adults 65 years and older, the target systolic blood pressure is <130 mmHg (no specific diastolic target recommended) 5, 6
  • High-risk patients should achieve a blood pressure of <130/80 mmHg or systolic <130 mmHg 1, 2, 3, 4, 7
  • The ACC/AHA guidelines define high-risk status as having known cardiovascular disease, diabetes mellitus, chronic kidney disease, or a high calculated cardiovascular risk (≥10% 10-year ASCVD risk) 1, 2, 3, 4, 5, 6

Treatment Initiation Thresholds

  • For high-risk patients, initiate pharmacological treatment at a blood pressure of ≥130/80 mmHg 5, 6, 1, 2, 4
  • For standard-risk patients, initiate pharmacological treatment at a blood pressure of ≥140/90 mmHg 5, 6, 1, 2, 4

Treatment Intensity Based on Initial BP

  • For Stage 2 hypertension (≥140/90 mmHg), initiate treatment with two-drug combination therapy when blood pressure is >20/10 mmHg above goal 5, 6, 7
  • Preferably use single-pill combination to improve adherence 1, 2, 3, 4

Important Caveats and Pitfalls

  • Avoid lowering diastolic blood pressure below 60 mmHg in high-risk patients with treated systolic blood pressure <130 mmHg, as this may increase cardiovascular events 1, 2, 3, 4
  • Optimal diastolic blood pressure appears to be 70-80 mmHg in this population 1, 2, 3, 4

Monitoring to Achieve Goals

  • Monthly follow-up after initiating or changing medications until target blood pressure is achieved 1, 2, 3, 4, 7
  • Every 3-5 months for patients at goal 1, 2, 3, 4
  • Assess both adherence and response at each visit 7
  • For patients on ACE inhibitors, ARBs, or diuretics, monitor renal function and potassium within the first 3 months 7